SlideShare a Scribd company logo
APPRAISING EVIDENCE ABOUT
PROGNOSTIC (RISK) FACTORS
INTRODUCTION
Prognosis:
 It is the process of predicting the future about a
patient client condition.
 Physical therapist develop prognoses about :
1. The risk of developing a future problem
2. The ultimate outcome of an impairment in body
structures or function, an activity limitation or a
participation restriction.
3. The result of physical therapy interventions.
 Prognostic estimates are formulated in response
to questions posed by patientsclients and their
families, as well as to indicate the response of
the therapist’s plan of care.
 In both instances the predicted outcome includes
a time frame for its development to satisfy
patientclient expectations as well as to address
payer interests with respect to the duration and
intensity of the physical therapy episode of care.
Risk of a future adverse event:
 Physical therapists concerns about the risk for
developing future problems generally are focused on
patients for whom a primary medical diagnosis or
impairment already is established
 Examples for potential problems:
1. Skin breakdown as a result of sensation loss( as in
DM and stroke) and immobility ( as SCI and casting)
2. Re injury with return to work or athletic activities
following joint sprain and muscle strain
3. Falls as a result of neurological insult ( as in stroke
or brain injury)
 Physical therapists formulate prognoses related to
the ultimate outcome of movement related
impairments in body structures and functions, activity
limitations, and participations restrictions.
 Prognostic questions regarding ultimate outcomes
are
1. Will I always need oxygen for activity?
2. Will I walk without a walker again?
3. Will my shoulder always be painful when I pitch?
4. Will my child be able to attend school like other
children?
 These are the questions raised by patients and
caregivers as well as by students and professionals
with limited experience with various patient
Results from physical therapy interventions
 Predictions about the results produced by
interventions are reflected in the goals physical
therapist write for their patientsclients.
 In addition this information is tied to a timeline such
as the no. of days, weeks or visits that is anticipated
to achieve the specified outcomes.
 The therapist’s challenge is to consider the likelihood
of achievement, within the specified time line, of the
outcomes identified for a given patient/client.
 Eg : a patient, ability to learn a home ex’s program
prior to hospital discharge following total knee
arthroplasty may depend on the individual's cognitive
abilities and support from family or caregivers
Elements of prognosis
 Three elements
1. The outcome(or outcomes) that are possible
2. The likelihood that the outcome(or outcomes will) occur
3. The frame required for their achievement
Study Credibility
 Evidence pertaining to prognostic factors first should
be evaluated with an assessment of its research
validity.
 Higher research validity provides greater confidence
that a study’s findings are reasonably free from bias.
In other words, the result are believable.
 Did the investigators operationally define the sample in
their study?
 One of the first concerns investigators must address with
respect to their sample is its definition
 Clearly articulated inclusion and exclusion criteria should
be used to ensure that subject fit the definition of
individual who have, or who are at risk for, the outcome of
interest.
 Where the subjects representative of the population from
which they were drawn ?
 The issue of representativeness pertains to the degree to
which investigators where able to capture all eligible
subjects during the time frame of the study.
 Did all subjects enter the study at the same
(preferably early ) stage of their condition?
 This question is particularly salient for longitudinal cohort
design designs. Investigators must determine at what
point patient should be gathered for study. This decision
depends in part on the nature of the outcome of interest
and in part on the research question.
 Was the study time frame long enough to capture the
outcomes of interest?
the length of follow up time of a study will depend on
which outcomes or events are being anticipated. The time
frame identified must be long enough for the human body
to achieve the outcome from a physiology or
psychological stand point. If the time is too short, then a
possible outcome will be missed.
 Did the investigators collect outcome data from all
the subjects enrolled in the study?
the ability to capture the outcomes of all the
subjects is important because attrition for any reason
may provide a skewed representation of which
outcomes occurred and when. Ideally, investigators
will be able to determine what happened to subjects
who left the study in order to evaluate whether the
outcomes were truly different than for those who
remained. Differences between subjects who
remained and subjects who dropped out indicate that
bias likely has been introduced to the prognostic
estimates.
 Were outcome criteria operationally defined?
this question addresses the validity of the measures
used to capture the outcomes of interest. A clear
definition of the outcome is necessary to avoid
misidentification. Investigators should articulate specific
clinical and/or testing criteria prior to the start of data
collection.
 Were the individuals collecting the outcome measures
masked ( or blinded) to the status of prognostic factors in
each subjects?
ideally, those measuring the outcomes will be masked, or
ignorant of the subjects prognostic (risk) factor. Prior
knowledge of subjects status may introduce teaser bias
into the study because expectations about the outcomes
may influence application and interpretation of the
measure used to capture them.
 Does the sample include subgroups of patients for
whom prognostic estimates will differ? If so, did the
investigators conduct separate subgroup analyses or
statistically adjust for these different prognostic
factors?
A subgroup is a smaller group of subjects who have
a characteristic that have a characteristic that
distinguishes them from the larger sample. This
characteristic is anticipated to influence the outcome
of interest such that a different prognostic estimate is
likely to be identified.
 Did investigators confirm their findings with a new
set of subjects?
This question alludes to the possibility that the
research findings regarding prognostic(risk) factors
occurred due to unique attributes of the sample.
Repeating the study on a second set of subjects who
match the inclusion and exclusion criteria outlined for
the first set provides an opportunity to evaluate
whether the same predictive factors are present.
STUDY RESULT
 Prognostic research uses both descriptive statics, as
well as tests of relationships to identify
prognostic(risk) factors.
THE STATISTICAL IMPORTANCE OF STUDY
RESULT
 In addition to the correlation coefficients, odds ratios,
relative risk, and hazard ratios reported in studies,
investigators also provide information to determine
the “meaningfulness” or potential importance of their
result. The two primary ways to convey potential
importance are via the p value and the confidence
interval. A p value indicates the probability that the
result obtained occurred due to chance. The smaller
the p value (eg., <0.005), the more important the
result is statistically because the role of chance is so
diminished although not eliminated.
EVIDENCE AND THE PATIENT/ CLIENT
 As with all evidence, a study about prognostic (risk)
factors must be examined to determine if the
subjects included resembles closely enough the
patient/ client to whom the results may be applied.
 The unique twist to the use of prognostic evidence is
the degree to which it will influence what therapists
will tell their patients / clients about their future, as
well as how treatment planning will be influenced, if
at all.
SUMMARY
 Prognosis is the process of predicting a future
outcome for a patient / client.
 Evidence about prognostic (risk) factors for
outcomes relevant to physical therapist is limited but
should be evaluated when possible to improve the
prognostic estimation process.

More Related Content

Similar to APPRAISING EVIDENCE ABOUT PROGNOSTIC (RISK) FACTORS.pptx

Validity of Evidence
Validity of EvidenceValidity of Evidence
Validity of Evidence
sahughes
 
study design of clinical research
study design of clinical researchstudy design of clinical research
study design of clinical research
MD Jahidul Islam
 
Excelsior College PBH 321 Page 1 EXPERI MENTAL E.docx
Excelsior College PBH 321     Page 1 EXPERI MENTAL E.docxExcelsior College PBH 321     Page 1 EXPERI MENTAL E.docx
Excelsior College PBH 321 Page 1 EXPERI MENTAL E.docx
gitagrimston
 
OBSERVATIONAL STUDIES PPT.pptx
OBSERVATIONAL STUDIES PPT.pptxOBSERVATIONAL STUDIES PPT.pptx
OBSERVATIONAL STUDIES PPT.pptx
KrishnaveniManubolu
 
QuickStart.ppt
QuickStart.pptQuickStart.ppt
QuickStart.ppt
AnandKumar459862
 
Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...
Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...
Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...
naseemashraf2
 
Research Methodology
Research MethodologyResearch Methodology
Research Methodology
Vince Calantas
 
Nursing process
Nursing processNursing process
Nursing process
Farooq Marwat
 
introduction to evidence based practice 1
introduction to evidence based practice 1introduction to evidence based practice 1
introduction to evidence based practice 1
NoorulAinShahid6
 
Research methodology
Research methodologyResearch methodology
Research methodology
monaaboserea
 
Applying evidence based
Applying evidence basedApplying evidence based
Applying evidence based
islam kassem
 
Level of Evidence- Dina Hudiya Nadana Lubis.pptx
Level of Evidence- Dina Hudiya Nadana Lubis.pptxLevel of Evidence- Dina Hudiya Nadana Lubis.pptx
Level of Evidence- Dina Hudiya Nadana Lubis.pptx
dina410715
 
5 tips for_selecting_prom
5 tips for_selecting_prom5 tips for_selecting_prom
5 tips for_selecting_prom
Keith Meadows
 
Error/Bais in Rsearch Methodology and pharmaceutical statistics
Error/Bais in Rsearch Methodology and pharmaceutical statisticsError/Bais in Rsearch Methodology and pharmaceutical statistics
Error/Bais in Rsearch Methodology and pharmaceutical statistics
akashpharma19
 
Judgment of causality2 kaleab
Judgment of causality2  kaleabJudgment of causality2  kaleab
Judgment of causality2 kaleab
kaleabtegegne
 
20050325 Design of clinical trails in radiology
20050325 Design of clinical trails in radiology20050325 Design of clinical trails in radiology
20050325 Design of clinical trails in radiology
Internet Medical Journal
 
Clinical research protocol
Clinical research protocolClinical research protocol
Clinical research protocol
Puneshwar Keshari
 
Development of clinical trail protocol
Development of clinical trail protocolDevelopment of clinical trail protocol
Development of clinical trail protocol
Pradnya Shirude
 
Evidence based practice in physiotherapy.pptx
Evidence based practice in physiotherapy.pptxEvidence based practice in physiotherapy.pptx
Evidence based practice in physiotherapy.pptx
DrNamrataMane
 
research design
research designresearch design
research design
Rajeshwori
 

Similar to APPRAISING EVIDENCE ABOUT PROGNOSTIC (RISK) FACTORS.pptx (20)

Validity of Evidence
Validity of EvidenceValidity of Evidence
Validity of Evidence
 
study design of clinical research
study design of clinical researchstudy design of clinical research
study design of clinical research
 
Excelsior College PBH 321 Page 1 EXPERI MENTAL E.docx
Excelsior College PBH 321     Page 1 EXPERI MENTAL E.docxExcelsior College PBH 321     Page 1 EXPERI MENTAL E.docx
Excelsior College PBH 321 Page 1 EXPERI MENTAL E.docx
 
OBSERVATIONAL STUDIES PPT.pptx
OBSERVATIONAL STUDIES PPT.pptxOBSERVATIONAL STUDIES PPT.pptx
OBSERVATIONAL STUDIES PPT.pptx
 
QuickStart.ppt
QuickStart.pptQuickStart.ppt
QuickStart.ppt
 
Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...
Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...
Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, ...
 
Research Methodology
Research MethodologyResearch Methodology
Research Methodology
 
Nursing process
Nursing processNursing process
Nursing process
 
introduction to evidence based practice 1
introduction to evidence based practice 1introduction to evidence based practice 1
introduction to evidence based practice 1
 
Research methodology
Research methodologyResearch methodology
Research methodology
 
Applying evidence based
Applying evidence basedApplying evidence based
Applying evidence based
 
Level of Evidence- Dina Hudiya Nadana Lubis.pptx
Level of Evidence- Dina Hudiya Nadana Lubis.pptxLevel of Evidence- Dina Hudiya Nadana Lubis.pptx
Level of Evidence- Dina Hudiya Nadana Lubis.pptx
 
5 tips for_selecting_prom
5 tips for_selecting_prom5 tips for_selecting_prom
5 tips for_selecting_prom
 
Error/Bais in Rsearch Methodology and pharmaceutical statistics
Error/Bais in Rsearch Methodology and pharmaceutical statisticsError/Bais in Rsearch Methodology and pharmaceutical statistics
Error/Bais in Rsearch Methodology and pharmaceutical statistics
 
Judgment of causality2 kaleab
Judgment of causality2  kaleabJudgment of causality2  kaleab
Judgment of causality2 kaleab
 
20050325 Design of clinical trails in radiology
20050325 Design of clinical trails in radiology20050325 Design of clinical trails in radiology
20050325 Design of clinical trails in radiology
 
Clinical research protocol
Clinical research protocolClinical research protocol
Clinical research protocol
 
Development of clinical trail protocol
Development of clinical trail protocolDevelopment of clinical trail protocol
Development of clinical trail protocol
 
Evidence based practice in physiotherapy.pptx
Evidence based practice in physiotherapy.pptxEvidence based practice in physiotherapy.pptx
Evidence based practice in physiotherapy.pptx
 
research design
research designresearch design
research design
 

Recently uploaded

DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 

Recently uploaded (20)

DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 

APPRAISING EVIDENCE ABOUT PROGNOSTIC (RISK) FACTORS.pptx

  • 2. INTRODUCTION Prognosis:  It is the process of predicting the future about a patient client condition.  Physical therapist develop prognoses about : 1. The risk of developing a future problem 2. The ultimate outcome of an impairment in body structures or function, an activity limitation or a participation restriction. 3. The result of physical therapy interventions.
  • 3.  Prognostic estimates are formulated in response to questions posed by patientsclients and their families, as well as to indicate the response of the therapist’s plan of care.  In both instances the predicted outcome includes a time frame for its development to satisfy patientclient expectations as well as to address payer interests with respect to the duration and intensity of the physical therapy episode of care.
  • 4. Risk of a future adverse event:  Physical therapists concerns about the risk for developing future problems generally are focused on patients for whom a primary medical diagnosis or impairment already is established  Examples for potential problems: 1. Skin breakdown as a result of sensation loss( as in DM and stroke) and immobility ( as SCI and casting) 2. Re injury with return to work or athletic activities following joint sprain and muscle strain 3. Falls as a result of neurological insult ( as in stroke or brain injury)
  • 5.  Physical therapists formulate prognoses related to the ultimate outcome of movement related impairments in body structures and functions, activity limitations, and participations restrictions.  Prognostic questions regarding ultimate outcomes are 1. Will I always need oxygen for activity? 2. Will I walk without a walker again? 3. Will my shoulder always be painful when I pitch? 4. Will my child be able to attend school like other children?  These are the questions raised by patients and caregivers as well as by students and professionals with limited experience with various patient
  • 6. Results from physical therapy interventions  Predictions about the results produced by interventions are reflected in the goals physical therapist write for their patientsclients.  In addition this information is tied to a timeline such as the no. of days, weeks or visits that is anticipated to achieve the specified outcomes.  The therapist’s challenge is to consider the likelihood of achievement, within the specified time line, of the outcomes identified for a given patient/client.  Eg : a patient, ability to learn a home ex’s program prior to hospital discharge following total knee arthroplasty may depend on the individual's cognitive abilities and support from family or caregivers
  • 7. Elements of prognosis  Three elements 1. The outcome(or outcomes) that are possible 2. The likelihood that the outcome(or outcomes will) occur 3. The frame required for their achievement
  • 8. Study Credibility  Evidence pertaining to prognostic factors first should be evaluated with an assessment of its research validity.  Higher research validity provides greater confidence that a study’s findings are reasonably free from bias. In other words, the result are believable.
  • 9.  Did the investigators operationally define the sample in their study?  One of the first concerns investigators must address with respect to their sample is its definition  Clearly articulated inclusion and exclusion criteria should be used to ensure that subject fit the definition of individual who have, or who are at risk for, the outcome of interest.  Where the subjects representative of the population from which they were drawn ?  The issue of representativeness pertains to the degree to which investigators where able to capture all eligible subjects during the time frame of the study.
  • 10.  Did all subjects enter the study at the same (preferably early ) stage of their condition?  This question is particularly salient for longitudinal cohort design designs. Investigators must determine at what point patient should be gathered for study. This decision depends in part on the nature of the outcome of interest and in part on the research question.  Was the study time frame long enough to capture the outcomes of interest? the length of follow up time of a study will depend on which outcomes or events are being anticipated. The time frame identified must be long enough for the human body to achieve the outcome from a physiology or psychological stand point. If the time is too short, then a possible outcome will be missed.
  • 11.  Did the investigators collect outcome data from all the subjects enrolled in the study? the ability to capture the outcomes of all the subjects is important because attrition for any reason may provide a skewed representation of which outcomes occurred and when. Ideally, investigators will be able to determine what happened to subjects who left the study in order to evaluate whether the outcomes were truly different than for those who remained. Differences between subjects who remained and subjects who dropped out indicate that bias likely has been introduced to the prognostic estimates.
  • 12.  Were outcome criteria operationally defined? this question addresses the validity of the measures used to capture the outcomes of interest. A clear definition of the outcome is necessary to avoid misidentification. Investigators should articulate specific clinical and/or testing criteria prior to the start of data collection.  Were the individuals collecting the outcome measures masked ( or blinded) to the status of prognostic factors in each subjects? ideally, those measuring the outcomes will be masked, or ignorant of the subjects prognostic (risk) factor. Prior knowledge of subjects status may introduce teaser bias into the study because expectations about the outcomes may influence application and interpretation of the measure used to capture them.
  • 13.  Does the sample include subgroups of patients for whom prognostic estimates will differ? If so, did the investigators conduct separate subgroup analyses or statistically adjust for these different prognostic factors? A subgroup is a smaller group of subjects who have a characteristic that have a characteristic that distinguishes them from the larger sample. This characteristic is anticipated to influence the outcome of interest such that a different prognostic estimate is likely to be identified.
  • 14.  Did investigators confirm their findings with a new set of subjects? This question alludes to the possibility that the research findings regarding prognostic(risk) factors occurred due to unique attributes of the sample. Repeating the study on a second set of subjects who match the inclusion and exclusion criteria outlined for the first set provides an opportunity to evaluate whether the same predictive factors are present.
  • 15. STUDY RESULT  Prognostic research uses both descriptive statics, as well as tests of relationships to identify prognostic(risk) factors.
  • 16. THE STATISTICAL IMPORTANCE OF STUDY RESULT  In addition to the correlation coefficients, odds ratios, relative risk, and hazard ratios reported in studies, investigators also provide information to determine the “meaningfulness” or potential importance of their result. The two primary ways to convey potential importance are via the p value and the confidence interval. A p value indicates the probability that the result obtained occurred due to chance. The smaller the p value (eg., <0.005), the more important the result is statistically because the role of chance is so diminished although not eliminated.
  • 17. EVIDENCE AND THE PATIENT/ CLIENT  As with all evidence, a study about prognostic (risk) factors must be examined to determine if the subjects included resembles closely enough the patient/ client to whom the results may be applied.  The unique twist to the use of prognostic evidence is the degree to which it will influence what therapists will tell their patients / clients about their future, as well as how treatment planning will be influenced, if at all.
  • 18.
  • 19.
  • 20. SUMMARY  Prognosis is the process of predicting a future outcome for a patient / client.  Evidence about prognostic (risk) factors for outcomes relevant to physical therapist is limited but should be evaluated when possible to improve the prognostic estimation process.